"Albuterol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
| Descriptor ID |
D000420
|
| MeSH Number(s) |
D02.033.100.291.057 D02.092.063.291.057 D02.092.471.683.061
|
| Concept/Terms |
Albuterol- Albuterol
- Salbutamol
- 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
|
Below are MeSH descriptors whose meaning is more general than "Albuterol".
Below are MeSH descriptors whose meaning is more specific than "Albuterol".
This graph shows the total number of publications written about "Albuterol" by people in this website by year, and whether "Albuterol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 0 | 3 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 2 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albuterol" by people in Profiles.
-
Asthma Care Protocol Implementation in the Pediatric Intensive Care Unit. Crit Care Nurs Clin North Am. 2023 Sep; 35(3):337-346.
-
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. BMJ Open. 2023 06 12; 13(6):e071311.
-
Evaluating the Clinical Impact of a Novel Pediatric Emergency Medicine Curriculum on Asthma Outcomes in Belize. Pediatr Emerg Care. 2022 Nov 01; 38(11):598-604.
-
Association of obesity with severity outcomes in hospitalized pediatric asthma exacerbations. J Asthma. 2022 Jan; 59(1):54-58.
-
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.
-
Association of various weight-based doses of continuous albuterol on hospital length of stay. J Asthma. 2021 05; 58(5):645-650.
-
Pharmacotherapy in bronchiolitis at discharge from emergency departments within the Pediatric Emergency Research Networks: a retrospective analysis. Lancet Child Adolesc Health. 2019 08; 3(8):539-547.
-
Acute Management of Hyperkalemia. Curr Heart Fail Rep. 2019 06; 16(3):67-74.
-
Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulm Pharmacol Ther. 2018 12; 53:20-26.
-
Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. Am J Respir Crit Care Med. 2018 06 15; 197(12):1552-1564.